Pervasip Announces $1.6 Million in August Revenues and 3rd Quarter Guidance

Rhea-AI Summary

Pervasip Corp. (OTC: PVSP) announced record sales of $1.6 million for August, marking its best sales month to date. CEO German Burtscher highlighted improvements in cash flow and restructuring efforts leading to better key financial performance indicators as the third quarter concludes. The company is focused on prioritizing margins over revenue and plans to introduce new product lines and acquisitions to enhance growth opportunities in the recreational cannabis market. This strategic shift aims to create a balanced revenue ratio across product categories.

Positive

• August sales reached $1.6 million, the highest in company history.
• Improvements in cash flow for Q3 reflect restructuring efforts.
• Strategic focus on margin improvement over revenue growth.
• Introduction of new product lines and planned acquisitions may boost revenue.

Negative

• None.

SEATTLE, WASHINGTON, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, together with Zen Asset Management, today announced that Artizen reached sales of $1.6 million in August.

“Marking the best sales month ever is a testament to the hard work of the team and quality of Artizen branded products in these difficult market conditions,” says German Burtscher, Pervasip’s CEO. “August also marks the close of the 3^rd quarter and the restructuring efforts of the last several months are starting to show improvement across many key financial performance indicators, including cashflow for Q3. As we further rationalize our business, including shedding of underperforming assets, we will continue to prioritize margins over revenue to build lasting financial health and strengthening fundamentals important to support our growth. We are achieving a more balanced ratio of revenues across all product categories which will serve the Company well as it goes into Q4.”

The Company also reports that various new product lines and planned near-term acquisitions will add revenue, new growth opportunities, and be a springboard for expansion into other recreational cannabis markets in the US.

Pervasip Corporation
Pervasip Corp., a developer of companies and technologies in high value emerging markets, owns Artizen Corporation and its subsidiary, Zen Asset Management LLC, a diversified asset management company founded to acquire, develop, and support companies and technologies in the cannabis industry. ZAM’s existing clients operate four licensed cannabis cultivation and one processing facility in Washington. Most of the biomass produced by these independent cultivators has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state. Additional information on Artizen-branded products is available online at www.artizencannabis.com. Pervasip additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin. Additional information on KRTL is available online at www.krtlbiotech.com. Additional information on Pervasip can be found at www.pervasip.net.

Forward-Looking Statements
This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as may, would, could, will, likely, except, anticipate, believe, intend, plan, forecast, project, estimate, outlook, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; ability to realize benefits from its recent corporate appointments; ability to retain its key personnel; the intention to grow the Company’s business and operations; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company. Forward-looking information is based on the assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; and the Company’s ability to secure financing on reasonable terms. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks as described in the Company’s periodic disclosure statements. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.

For further information, please contact:
T:            206-590-2408
E:            info@pervasip.net  

FAQ

What are Pervasip Corp's sales figures for August 2022?

Pervasip Corp reported sales of $1.6 million for August 2022.

How is Pervasip Corp performing financially in Q3?

The company is seeing improvements in cash flow and key financial performance indicators for Q3.

What operational changes is Pervasip Corp implementing?

Pervasip is prioritizing margins over revenue and shedding underperforming assets.

What future opportunities is Pervasip Corp pursuing?

Pervasip plans to introduce new product lines and acquisitions for revenue growth in the recreational cannabis market.